Vimarsana
Biggest News Aggregation in the World

Page 38 - Crispr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Crispr Today - Breaking & Trending Today

Scientists turn to Nobel Prize-winning gene editing tool to reduce dairy methane emissions - Vimarsana News

Scientists turn to Nobel Prize-winning gene editing tool to reduce dairy methane emissions

With a sizable grant from the TED Audacious Project, scientists at UC Davis, UC Berkeley and UC San Francisco are using the Nobel-Prize-winning gene editing tool known as CRISPR to attempt to reduce the methane released by dairy cows.

Source: kvpr.org
Vertex/CRISPR's Gene Editing Therapy Cost Effective at $1.9 Million: Pricing Review Group - Vimarsana News

Vertex/CRISPR's Gene Editing Therapy Cost Effective at $1.9 Million: Pricing Review Group

Vertex Pharmaceuticals and CRISPR Therapeutics's one-dose gene editing therapy for sickle cell disease would be cost effective if priced at up to $1.9 million, an influential US drug pricing group said on Wednesday.

Why Are Isoforms Linked to Tumor Subtypes? - Vimarsana News

Why Are Isoforms Linked to Tumor Subtypes?

Mutations in the identical genes lead to diverse subtypes of tumors in different individuals. Scientists have identified a new way to generate tumor subtypes.

Related Topics:
Liver CancerUmor Subtypes
It's Official: No More Crispr Babies—for Now - Vimarsana News

It's Official: No More Crispr Babies—for Now

In the face of safety risks, experts have tightened the reins on heritable genome editing—but haven’t ruled out using it someday.

Source: wired.com
New CRISPR Technique Restrores Vision in Blind Mice - Vimarsana News

New CRISPR Technique Restrores Vision in Blind Mice

A new CRISPR technique was employed by Chinese scientists to successfully restore vision in mice. Researchers in China have announced a groundbreaking discovery in the treatment of retinitis pigmentosa, a leading cause of blindness in humans.